Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2027 financial results after the close of market trading on Wednesday, Dec. 2, 2026. Phreesia will issue a
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sophia Wagner, Vice President of Product Engineering, has been named to Becker’s Hospital Review’s 2026 list of Health IT &
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Michael Rasbury, Vice President of AccessOne Solutions, has been named to Becker’s Hospital Review’s 2026 list of Rising Stars:
This new collaboration aims to learn more about how to support patients living with Parkinson’s disease
Phreesia, a leader in patient intake, outreach and activation that enables one in six patient visits across the
Phreesia, a leader in patient intake, outreach and activation, has been named to TIME’s list of the World’s Top HealthTech Companies of 2026. This marks the second consecutive year Phreesia has been recognized on the
Phreesia, a trusted leader in activation and healthcare media, today announced a partnership with DeepIntent, the leading healthcare marketing platform. Phreesia's ProviderConnect audiences are now available in the
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026. Phreesia will issue a
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and
This new collaboration reaches patients and their providers with information on widespread, preventable maternal health conditions
Phreesia, a leader in patient intake, outreach and activation that enables one in six
MediFind, a data-powered online provider directory offered by Phreesia, is announcing the launch of Chloe, its new "Find the Right Provider" chatbot. Chloe is designed to guide patients step by step through the
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. ("Phreesia" or the "Company") (NYSE:PHR). Such investors are advised to
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. ("Phreesia" or the "Company") (NYSE:PHR). Such investors are
New York, New York--(Newsfile Corp. - July 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE:PHR) between May 8, 2025 and March 30, 2026,
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE:PHR) between May 8, 2025 and March 30, 2026, inclusive
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in
